{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:43:16Z","timestamp":1790066596327,"version":"4.0.1"},"reference-count":44,"publisher":"Portland Press Ltd.","issue":"3","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"abstract":"<jats:p>Muscle microvascular surface area determines substrate and hormonal exchanges between plasma and muscle interstitium. GLP-1 (glucagon-like peptide-1) regulates glucose-dependent insulin secretion and has numerous extrapancreatic effects, including a salutary vascular action. To examine whether GLP-1 recruits skeletal and cardiac muscle microvasculature in healthy humans, 26 overnight-fasted healthy adults received a systemic infusion of GLP-1 (1.2\u00a0pmol\/kg of body mass per min) for 150\u00a0min. Skeletal and cardiac muscle MBV (microvascular blood volume), MFV (microvascular flow velocity) and MBF (microvascular blood flow) were determined at baseline and after 30 and 150\u00a0min. Brachial artery diameter and mean flow velocity were measured and total blood flow was calculated before and at the end of the GLP-1 infusion. GLP-1 infusion raised plasma GLP-1 concentrations to the postprandial levels and suppressed plasma glucagon concentrations with a transient increase in plasma insulin concentrations. Skeletal and cardiac muscle MBV and MBF increased significantly at both 30 and 150\u00a0min (P&amp;lt;0.05). MFV did not change in skeletal muscle, but decreased slightly in cardiac muscle. GLP-1 infusion significantly increased brachial artery diameter (P&amp;lt;0.005) and flow velocity (P=0.05) at 150\u00a0min, resulting in a significant increase in total brachial artery blood flow (P&amp;lt;0.005). We conclude that acute GLP-1 infusion significantly recruits skeletal and cardiac muscle microvasculature in addition to relaxing the conduit artery in healthy humans. This could contribute to increased tissue oxygen, nutrient and insulin delivery and exchange and therefore better prandial glycaemic control and tissue function in humans.<\/jats:p>","DOI":"10.1042\/cs20130708","type":"journal-article","created":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T09:56:31Z","timestamp":1392976591000},"page":"163-170","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["GLP-1 at physiological concentrations recruits skeletal and cardiac muscle microvasculature in healthy humans"],"prefix":"10.1042","volume":"127","author":[{"given":"Sharmila\u00a0C.","family":"Subaran","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew\u00a0A.","family":"Sauder","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Chai","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda\u00a0A.","family":"Jahn","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale\u00a0E.","family":"Fowler","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin\u00a0W.","family":"Aylor","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda","family":"Basu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Mayo Clinic, Rochester, MN 55905, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqi","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"key":"2021113010324598500_B1","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"2021113010324598500_B2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab."},{"key":"2021113010324598500_B3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.50.3.609","article-title":"Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1\u00a0in type\u00a02 diabetic patients","volume":"50","author":"Vilsboll","year":"2001","journal-title":"Diabetes"},{"key":"2021113010324598500_B4","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jcem.86.8.7750","article-title":"Determinants of the impaired secretion of glucagon-like peptide-1\u00a0in type\u00a02 diabetic patients","volume":"86","author":"Toft-Nielsen","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010324598500_B5","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1210\/jc.2002-021873","article-title":"Incretin secretion in relation to meal size and body weight in healthy subjects and people with type\u00a01 and type\u00a02 diabetes mellitus","volume":"88","author":"Vilsboll","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010324598500_B6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/BF00274255","article-title":"The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with Type\u00a02 (non-insulin-dependent) diabetes mellitus","volume":"32","author":"Jones","year":"1989","journal-title":"Diabetologia"},{"key":"2021113010324598500_B7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI116186","article-title":"Preserved incretin activity of glucagon-like peptide 1 [7\u201336 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus","volume":"91","author":"Nauck","year":"1993","journal-title":"J. Clin. Invest."},{"key":"2021113010324598500_B8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-0028-1082326","article-title":"The potential beneficial role of glucagon-like peptide-1\u00a0in endothelial dysfunction and heart failure associated with insulin resistance","volume":"40","author":"Nystrom","year":"2008","journal-title":"Horm. Metab. Res."},{"key":"2021113010324598500_B9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.regpep.2004.08.024","article-title":"Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism","volume":"125","author":"Nystr\u00f6m","year":"2005","journal-title":"Regul. Pept."},{"key":"2021113010324598500_B10","doi-asserted-by":"crossref","first-page":"E1209","DOI":"10.1152\/ajpendo.00237.2004","article-title":"Effects of glucagon-like peptide-1 on endothelial function in type\u00a02 diabetes patients with stable coronary artery disease","volume":"287","author":"Nystrom","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2021113010324598500_B11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00004872-200306000-00012","article-title":"Antihypertensive effect of glucagon-like peptide 1\u00a0in Dahl salt-sensitive rats","volume":"21","author":"Yu","year":"2003","journal-title":"J. Hypertens."},{"key":"2021113010324598500_B12","doi-asserted-by":"crossref","first-page":"E1289","DOI":"10.1152\/ajpendo.00373.2007","article-title":"Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride","volume":"293","author":"Basu","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2021113010324598500_B13","doi-asserted-by":"crossref","first-page":"L374","DOI":"10.1152\/ajplung.1993.265.4.L374","article-title":"GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery","volume":"265","author":"Richter","year":"1993","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"2021113010324598500_B14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0167-0115(01)00300-7","article-title":"Vasorelaxant effect of glucagon-like peptide-(7\u201336)amide and amylin on the pulmonary circulation of the rat","volume":"102","author":"Golpon","year":"2001","journal-title":"Regul. Pept."},{"key":"2021113010324598500_B15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/db11-1073","article-title":"Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism","volume":"61","author":"Chai","year":"2012","journal-title":"Diabetes"},{"key":"2021113010324598500_B16","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1152\/ajpendo.00473.2012","article-title":"Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment","volume":"304","author":"Dong","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2021113010324598500_B17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2010.04.022","article-title":"Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K\/Akt-dependent pathways and requires GLP-1 receptor","volume":"325","author":"Erdogdu","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"2021113010324598500_B18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.0000139339.85840.DD","article-title":"Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy","volume":"110","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"2021113010324598500_B19","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00125-009-1313-z","article-title":"The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action","volume":"52","author":"Barrett","year":"2009","journal-title":"Diabetologia"},{"key":"2021113010324598500_B20","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1152\/ajpendo.00186.2011","article-title":"Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature","volume":"301","author":"Barrett","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2021113010324598500_B21","doi-asserted-by":"crossref","first-page":"E1250","DOI":"10.1152\/ajpendo.00451.2007","article-title":"Insulin at physiological concentrations increases microvascular perfusion in human myocardium","volume":"293","author":"Liu","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2021113010324598500_B22","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1210\/jc.2009-0027","article-title":"Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature","volume":"94","author":"Liu","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010324598500_B23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/jc.2010-1174","article-title":"Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans","volume":"96","author":"Liu","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010324598500_B24","doi-asserted-by":"crossref","first-page":"E1208","DOI":"10.1210\/jc.2011-3455","article-title":"Candesartan acutely recruits skeletal and cardiac muscle microvasculature in healthy humans","volume":"97","author":"Sauder","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010324598500_B25","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1210\/jc.2003-030049","article-title":"Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1\u00a0in patients with type\u00a02 diabetes","volume":"88","author":"Meier","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010324598500_B26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0026-0495(94)90164-3","article-title":"Effect of glucagon-like peptide-1 (proglucagon 78\u2013107amide) on hepatic glucose production in healthy man","volume":"43","author":"Hvidberg","year":"1994","journal-title":"Metabolism"},{"key":"2021113010324598500_B27","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.2337\/diabetes.50.12.2682","article-title":"Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment","volume":"50","author":"Coggins","year":"2001","journal-title":"Diabetes"},{"key":"2021113010324598500_B28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1549-8719.2012.00174.x","article-title":"Insulin-induced microvascular recruitment in skin and muscle are related and both are associated with whole-body glucose uptake","volume":"19","author":"Meijer","year":"2012","journal-title":"Microcirculation"},{"key":"2021113010324598500_B29","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010324598500_B30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jc.2011-2561","article-title":"Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes","volume":"97","author":"Smushkin","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010324598500_B31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000120505.91348.58","article-title":"Effects of glucagon-like peptide-1\u00a0in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion","volume":"109","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"2021113010324598500_B32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1258\/ebm.2011.011288","article-title":"Intracoronary glucagon-like peptide 1 preferentially augments glucose uptake in ischemic myocardium independent of changes in coronary flow","volume":"237","author":"Moberly","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"2021113010324598500_B33","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.amjcard.2007.05.022","article-title":"Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting","volume":"100","author":"Sokos","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"2021113010324598500_B34","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.2337\/dc09-0206","article-title":"Obesity blunts microvascular recruitment in human forearm muscle after a mixed meal","volume":"32","author":"Keske","year":"2009","journal-title":"Diabetes Care"},{"key":"2021113010324598500_B35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/HYPERTENSIONAHA.109.145409","article-title":"Angiotensin II type\u00a01 and type\u00a02 receptors regulate basal skeletal muscle microvascular volume and glucose use","volume":"55","author":"Chai","year":"2010","journal-title":"Hypertension"},{"key":"2021113010324598500_B36","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1124\/jpet.106.100982","article-title":"Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts","volume":"317","author":"Zhao","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021113010324598500_B37","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2337\/dc10-2345","article-title":"Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans","volume":"34","author":"Chai","year":"2011","journal-title":"Diabetes Care"},{"key":"2021113010324598500_B38","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2337\/db05-1373","article-title":"Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle","volume":"55","author":"Clerk","year":"2006","journal-title":"Diabetes"},{"key":"2021113010324598500_B39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2337\/diabetes.53.2.447","article-title":"Insulin sensitivity of muscle capillary recruitment in\u00a0vivo","volume":"53","author":"Zhang","year":"2004","journal-title":"Diabetes"},{"key":"2021113010324598500_B40","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1210\/en.2008-0945","article-title":"The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action","volume":"150","author":"Ayala","year":"2009","journal-title":"Endocrinology"},{"key":"2021113010324598500_B41","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2337\/diab.46.9.1381","article-title":"Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment","volume":"46","author":"Rattigan","year":"1997","journal-title":"Diabetes"},{"key":"2021113010324598500_B42","doi-asserted-by":"crossref","first-page":"R809","DOI":"10.1152\/ajpregu.1994.266.3.R809","article-title":"Effects of adrenergic and cholinergic block-ade on insulin-induced stimulation of calf blood flow in humans","volume":"266","author":"Randin","year":"1994","journal-title":"Am. J. Physiol. Regul. Integrat. Comp. Physiol."},{"key":"2021113010324598500_B43","doi-asserted-by":"crossref","first-page":"H1096","DOI":"10.1152\/ajpheart.00930.2009","article-title":"Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure","volume":"298","author":"Halbirk","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113010324598500_B44","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s00125-011-2440-x","article-title":"Effects of intravenous exenatide in type\u00a02 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety","volume":"55","author":"Nathanson","year":"2012","journal-title":"Diabetologia"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/127\/3\/163\/444820\/cs1270163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/127\/3\/163\/444820\/cs1270163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:24:33Z","timestamp":1638271473000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/127\/3\/163\/70653\/GLP-1-at-physiological-concentrations-recruits"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20130708","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,3]]}}}